Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Coated Glucose Beads (APH-012/APH-001) in Obese Subjects
NCT05713773Phase 1Completed
- Sponsor
- Aphaia Pharma
- Start
- Oct 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of APHD-012 in obesity and metabolic syndrome (5 arms), sponsored by Aphaia Pharma. Primary endpoint: Glucagon-like peptide-1 levels at 10 hours. Started Oct 2019; status: completed.
02
Drugs
APHD-012
03
Conditions
obesitymetabolic syndrome
Beyond the preview
Go deeper on NCT05713773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05713773.